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Main Group Elements and Medicine
gastric and duodenal ulcers:
De-Nol®             Pepto-Bismol®            Pylorid® 
(coll-Bi subcitrate)         (Bi subsalicylate)       (rantidine Bi citrate)
Bismuth and Medicine










C & N News, October 10, 2005
http://www.pcsg.org.uk/html/dis_helicobacter.html




Mechanism of action (?):
IPNET.LAB








Bismuth compounds and cancer
Bismuth compounds: pro-drugs
H.p. causative agent for gastrointestinal cancers
WHO: class 1 carcinogen
Bismuth compounds and cancer
Bismuth compounds: pro-drugs
H.p. causative agent for gastrointestinal cancers
WHO: class 1 carcinogen
Combine bismuth with ‘useful’ thiols
Bismuth compounds and cancer
Dithiocarbamates in biology
Radiation therapy: inhibition of SOD
Dithiocarbamates in biology
Radiation therapy: inhibition of SOD
Anti-cancer effects:
reduces alkylation of DNA
combination therapy with cisplatin
Dithiocarbamates in biology
Significant contribution of: 






Pt, Pd, Sn & Au: anti-tumour potential
Metal dithiocarbamates in medicine
Hogath (2012)











Bi(dedtc)3 < 3.2 4
TAX < 3.2 < 3.2
Cytotoxicity (ID50; ng/ml):


















Six 100 year old trees / one patient
Ceased harvesting 1993
Taxol (Paclitaxel®)
Synthesis of Taxol (Paclitaxel®)
ChemEngNews 2003 Sept. 15th
Semi-synthetic route:  
taxane from English
yew tree – 35% yield
Synthesis of Taxol (Paclitaxel®)
Multi-step organic synthesis
e.g. Holton synthesis: 40 steps – 2% yield
ChemEngNews 2003 Sept. 15th
Semi-synthetic route:  
taxane from English






Alkyl chain             Me < Et > nPr > nBu
Branching              nPr > iPr & nBu > iBu
Ring                              n = 4 > n = 7
Aromatic                         inactive
Structure/activity relationship
Maximum Tolerated Dose – Balb/C mice







Bi(S2CNEt2)3: 7 mg Bi / kg
Bi(S2CNBu2)3: > 50 mg Bi / kg
Oral administration
Bi(S2CNEt2)3: ~ 50 mg Bi / kg
Maximum Tolerated Dose – Balb/C mice
MTD – Balb/C mice
- Ovcar: Ovarian cancer
MTD = 7 mg Bi / kg
ID50 = < 3.2 ng Bi / kg
“Therapeutic index”
= > 2.2 x 106
Anti-tumour activity – Balb/C Nude mice
Anti-tumour activity – Balb/C Nude mice
Anti-tumour activity: OVCAR


















































HepG2 cell death: apoptosis
Membrane permeability, DNA fragmentation,
caspase activities and PCR-array analysis indicate
extrinsic and intrinsic pathways
Cell cycle analysis, ROS, cytochrome C, cell invasion…
Average of 16 strains
Et N(CH2)4 n-Bu BSS
4                 8           256            16
MIC90 (µg/ml)
Killing Helicobacter pylori
with A/Prof Ho Bow & Sook Yin Lui

































Sun Hongzhe et al.
Anti-bacterial activity
Bactericidal against Streptococcus pneumoniae
Exciting potential for medicine with important








7th Asian Conference on Coordination Chemistry (ACCC7)
22-26 July 2019 / Kuala Lumpur, Malaysia
(Organised by Institut Kimia Malaysia)
You are welcome to visit the conference’s website at www.accc7.org.my for
updates on ACCC7 or you can email us at accc7@ikm.org.my for further
details.
Announcement
